News
Self Care Week - Community Newsletter
11/11/20
Keith Mahoney, one of our committee members, has sent in an electronic copy of a Community Newsletter from Cheshire East Council. The subject is Self Care Week which runs from 16th to 22nd November 2020. The newsletter is 22 pages and contains much useful information including local contacts and advice that might be useful to all of us especially during lockdown 2…
Home PSA Testing Kit now available from GFCT
26/10/20
During the current difficulties surrounding the COVID-19 pandemic, conventional blood testing events are unlikely to resume for some time. However, we are now able to offer you an opportunity to take a small blood sample at home for PSA analysis. This is done through The Graham Fulford Trust and TDL, who we have worked with for many years now and who have issued and maintained your history of previous test results…
Prostate Cancer Referrals Drop by 50% owing to Coronavirus
11/09/20
The Daily Mail reports "Prostate cancer referrals have halved since the beginning of lockdown as thousands of men put off seeing their GP". 27,000 fewer men have been referred to a specialist with suspected cases compared to the same period last year, according to analysis of offical NHS data by Prostate Cancer UK…
News Update from Cancer Research UK - Stories from Before Lockdown
06/07/20
We know the world has turned a bit upside down recently, so we've rounded up some positive cancer research stories from before lockdown that we haven't had the chance to share with you yet. From a new treatment for breast cancer being approved, to understanding pancreatic cancer, there's lots to catch up on…
NICE rejection of use of Abiraterone for men with newly-diagnosed metastatic prostate cancer in England and Wales
06/07/20
You may have already found out that a recent decision has been made by NICE not to approve the use of abiraterone as an additional treatment with hormone therapy in men newly diagnosed with advanced prostate cancer in England and Wales. This was being appraised as an alternative to the current standard of treatment regime which combines hormone therapy and docetaxel…
Mens Health Forum - Features Mens Health Week 16th - 20th June 2020
17/06/20
Mens Health Forum have special features on their website for Mens Health Week 16th - 21st June 2020, timed for the run-up to Fathers day. A key message on the website about the virus is "Men are Twice as Likely to Die"…
Staying In Quiz hosted by Stephen Fry, Bill Turnbull Wednesday 17th June at 8pm
16/06/20
Jeff Stelling, Gemma Oaten and many more host a star-studded quiz to raise money for prostate cancer research that's now at risk due to lack of funding. PCUK says "we won’t be returning to our local for a little while, so let the pub quiz fun come to you…
At Home with Bill Turnbull - Watch the Video on the PCUK website
16/06/20
Bill Turnbull has made a video for Prostate Cancer UK in which he discusses life under lockdown, his dogs and his bees in context of his battle with advanced Prostate Cancer. Bill had left his job as Breakfast TV presenter some time ago and discovered he had Prostate Cancer. He is now working as a presenter on Classic FM and as an ambassador for Prostate Cancer UK…
Prostate becomes the most common Cancer in the UK - 10 Years Earlier than Predicted
04/06/20
Prostate cancer becomes the UK’s most commonly diagnosed cancer –
10 years earlier than predicted
Prostate cancer has become the UK’s most commonly diagnosed cancer for the first time, according to the latest¹ UK-wide statistics² shared by Prostate Cancer UK…
FDA Approves Olaparib for Treatment of Advanced Prostate Cancer - Prostate Cancer Research Centre Report
20/05/20
The Prostate Cancer Research Centre reports:
This has been a truly historic week, with two new treatment options receiving FDA approval for men with advanced prostate cancer. Today, olaparib was approved by the FDA for certain metastatic prostate cancers that are not responsive to hormone therapy. Just last Friday, another drug in the class referred to as PARP inhibitors, rucaparib, was also approved…